Abstract Spindle Cell Hemangioma (SCH) is a vascular tumour first described in 1986 by Dr. Sharon Weiss. It was initially considered to be a low grade malignant tumour due to its propensity for lymph node metastasis and recurrance after excision. But due to its excellent prognosis, it is now considered to be a benign tumour. It shows a male preponderance with the most common site affected being distal extremities. SCH is a pathological diagnosis with combined features of Cavernous Hemangioma and Kaposi’s sarcoma on histology.